$MBVX | Undervalued Biotech With Strong Pipeline

Posted in CEOLIVE Insider

MabVax Therapeutics Holdings, Inc. is cancer diagnostic and immunotherapy company focused on the development of vaccine and antibody based therapies to address unmet medical needs in the treatment of cancer. MabVax has discovered a pipeline of human monoclonal antibody products based on the protective immune responses generated by patients who have been immunized against targeted cancers with the Company's proprietary vaccines.

The Company's lead antibody candidate HuMab 5B1 is being developed as both a diagnostic product and therapeutic agent for the diagnosis and treatment of GI cancers and specifically pancreatic cancer. The antibody product is scheduled to enter Phase I clinical trials later this year. MabVax has the exclusive license to a portfolio of therapeutic vaccines from Memorial Sloan Kettering Cancer Center. The Company has two cancer vaccines targeting recurrent sarcoma and ovarian cancer in proof of concept Phase II multi-center clinical trials, and plans to have a third vaccine targeting neuroblastoma ready for Phase II clinical development later this year.

This video interview may include forward-looking statements that involve risks and uncertainties. Forward- looking statements are statements that are not historical facts and are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. To read our full disclosure, please go to: http://ceolive.tv/disclaimer.

Disclosure: Neither CEOLIVE.TV or any of its principals currently owns or plan to own within 72 hours of publication any shares of the stocks mentioned in this video.

Related Articles on SeekingAlpha.com:

11/17/12014 - MabVax Is Under The Radar, But Undervalued: CEO David Hansen

CEO Interview | KRED

KonaRed Corp. Bringing the health & wellness attributes of Hawaiian CoffeeBerry to the masses.

read more

CEO Interview | MRIB

Marani Brands Develops, positions, markets and distributes fine wine and spirit products in the US.

read more

CEO Interview | OWOO

One World Holdings Making significant positive cultural impact through its Prettie Girls multi-cultural doll line.

read more

CEO Interview | SPRT

Support.com A leading provider of cloud-based services and software to enhance clients' experience.

read more